173 related articles for article (PubMed ID: 2454995)
1. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
Burger R; Zilow G; Bader A; Friedlein A; Naser W
J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of C3a by ELISA using a monoclonal antibody to a neoantigenic C3a determinant.
Zilow G; Naser W; Friedlein A; Bader A; Burger R
Prog Clin Biol Res; 1989; 308():299-304. PubMed ID: 2476822
[No Abstract] [Full Text] [Related]
4. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.
Hack CE; Paardekooper J; Smeenk RJ; Abbink J; Eerenberg AJ; Nuijens JH
J Immunol; 1988 Sep; 141(5):1602-9. PubMed ID: 2457622
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.
Zilow G; Naser W; Rutz R; Burger R
J Immunol Methods; 1989 Jul; 121(2):261-8. PubMed ID: 2503562
[TBL] [Abstract][Full Text] [Related]
6. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
7. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
8. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
Rotllant J; Parra D; Peters R; Boshra H; Sunyer JO
Dev Comp Immunol; 2004 Jun; 28(7-8):815-28. PubMed ID: 15043949
[TBL] [Abstract][Full Text] [Related]
9. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
[TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxin-mediated regulation of human and murine immune responses.
Morgan EL; Weigle WO; Hugli TE
Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
[TBL] [Abstract][Full Text] [Related]
11. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
12. Suppression of humoral immune responses by synthetic C3a peptides.
Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
[TBL] [Abstract][Full Text] [Related]
13. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
Dawson P; Turner MW; Bradshaw A; Westaby S
Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
[TBL] [Abstract][Full Text] [Related]
14. The active site of C3a anaphylatoxin.
Caporale LH; Tippett PS; Erickson BW; Hugli TE
J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
[TBL] [Abstract][Full Text] [Related]
15. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
[TBL] [Abstract][Full Text] [Related]
16. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
[TBL] [Abstract][Full Text] [Related]
17. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies.
Ying SC; Gewurz H; Kinoshita CM; Potempa LA; Siegel JN
J Immunol; 1989 Jul; 143(1):221-8. PubMed ID: 2471736
[TBL] [Abstract][Full Text] [Related]
18. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
Närkiö-Mäkelä M; Teppo AM; Meri S
Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
[TBL] [Abstract][Full Text] [Related]
19. The primary structure of porcine C3a anaphylatoxin.
Corbin NC; Hugli TE
J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
[TBL] [Abstract][Full Text] [Related]
20. Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3.
Palarasah Y; Skjodt K; Brandt J; Teisner B; Koch C; Vitved L; Skjoedt MO
J Immunol Methods; 2010 Oct; 362(1-2):142-50. PubMed ID: 20869965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
